Lingfang Wang

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Corrigendum to: GPX4 Inhibition Enhances the Antitumor Effect of PARP Inhibitor on Homologous Recombination Proficient Ovarian Cancer Cells.

Corrigendum to: GPX4 Inhibition Enhances the Antitumor Effect of PARP Inhibitor on Homologous Recombination Proficient Ovarian Cancer Cells.

Journal: Current cancer drug targets

Published: June 23, 2026

Erratum: Effects of lysate/tissue storage at -80°C on subsequently extracted EVs of epithelial ovarian cancer tissue origins.

Erratum: Effects of lysate/tissue storage at -80°C on subsequently extracted EVs of epithelial ovarian cancer tissue origins.

Journal: iScience

Published: February 13, 2026

Integrated spatial multi-omics delineates fatty acid degradation fuels malignant evolution at the tumour periphery in cervical squamous cell carcinoma.

Integrated spatial multi-omics delineates fatty acid degradation fuels malignant evolution at the tumour periphery in cervical squamous cell carcinoma.

Journal: EBioMedicine

Published: December 01, 2025

The distribution of colposcopy directed ectocervical biopsy and endocervical curettage results: a retrospective study of 47,134 cases.

The distribution of colposcopy directed ectocervical biopsy and endocervical curettage results: a retrospective study of 47,134 cases.

Journal: Annals of medicine

Published: October 16, 2025

Analysis of follow-up outcomes in patients with cervical histologic low-grade squamous intraepithelial lesion preceded by serious cytology and repeated diagnosis for at least 2 years.

Analysis of follow-up outcomes in patients with cervical histologic low-grade squamous intraepithelial lesion preceded by serious cytology and repeated diagnosis for at least 2 years.

Journal: Women's health (London, England)

Published: September 11, 2025

PCO25-211: HIF-1α Inhibitor ACF Synergizes With PARP Inhibitors Through the Exacerbation of Transcription-Replication Conflicts in Ovarian Cancer.

PCO25-211: HIF-1α Inhibitor ACF Synergizes With PARP Inhibitors Through the Exacerbation of Transcription-Replication Conflicts in Ovarian Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2025

QIM25-239: Hyperthermia Enhancing the Effect of Olaparib by Inducing Ferroptosis in Ovarian Cancer.

QIM25-239: Hyperthermia Enhancing the Effect of Olaparib by Inducing Ferroptosis in Ovarian Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 28, 2025

Efficacy of 5-aminolevulinic acid photodynamic therapy versus observation for cervical low-grade squamous intraepithelial lesion with type 3 transformation zone.

Efficacy of 5-aminolevulinic acid photodynamic therapy versus observation for cervical low-grade squamous intraepithelial lesion with type 3 transformation zone.

Journal: Photodiagnosis and photodynamic therapy

Published: March 26, 2025

Targeting Lactate Metabolism in Cancer Therapy: The Mechanism of Lactylation Modification and Prospects of Therapeutic Strategies.

Targeting Lactate Metabolism in Cancer Therapy: The Mechanism of Lactylation Modification and Prospects of Therapeutic Strategies.

Journal: Current cancer drug targets

Published: March 04, 2025

Viral integration and fusion transcript characteristics of possibly high-risk HPV in cervical cancer.

Viral integration and fusion transcript characteristics of possibly high-risk HPV in cervical cancer.

Journal: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases

Published: February 20, 2025

Mitochondrial fatty acid oxidation as the target for blocking therapy-resistance and inhibiting tumor recurrence: The proof-of-principle model demonstrated for ovarian cancer cells.

Mitochondrial fatty acid oxidation as the target for blocking therapy-resistance and inhibiting tumor recurrence: The proof-of-principle model demonstrated for ovarian cancer cells.

Journal: Journal of advanced research

Published: December 17, 2024

Update on Combination Strategies of PARP Inhibitors.

Update on Combination Strategies of PARP Inhibitors.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: November 05, 2024

Showing 1-12 of 38

Last Updated: 09/26/2026